Back

H3.3 contributes to chromatin accessibility and transcription factor binding at promoter-proximal regulatory elements

Tafessu, A.; O'Hara, R.; Martire, S.; Dube, A. L.; Saha, P.; Banaszynski, L. A.

2022-07-02 genomics
10.1101/2022.06.30.498282 bioRxiv
Show abstract

BackgroundThe histone variant H3.3 is enriched at active regulatory elements such as promoters and enhancers in mammalian genomes. These regions are highly accessible, creating an environment that is permissive to transcription factor binding and the recruitment of transcriptional coactivators that establish a unique chromatin post-translational landscape. How H3.3 contributes to the establishment and function of chromatin states at these regions is poorly understood. ResultsWe performed genomic analyses of features associated with active promoter chromatin in mouse embryonic stem cells (ESCs) and found evidence of subtle yet widespread promoter dysregulation in the absence of H3.3. Loss of H3.3 deposition at promoters reduces chromatin accessibility and transcription factor (TF) footprinting for nearly all TFs expressed in ESCs. H3.3 deletion leads to reduced promoter enrichment of the transcriptional coactivator and histone acetyltransferase, p300. Subsequently, histone H3 acetylation at lysine 27 (H3K27ac) is reduced at promoters in the absence of H3.3, along with reduced enrichment of the bromodomain-containing protein BRD4, an acetyl lysine reader. Despite the observed chromatin dysregulation, H3.3 KO ESCs maintain transcription from ESC-specific genes. However, upon undirected differentiation, H3.3 KO cells retain footprinting of ESC-specific TFs motifs and fail to generate footprints of lineage-specific TF motifs, in line with their diminished capacity to differentiate. ConclusionsH3.3 facilitates DNA accessibility, TF binding, and histone post-translational modification at active promoters. While H3.3 is not required for maintaining transcription in ESCs, it is required for TF binding at new promoters during differentiation.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Epigenetics
43 papers in training set
Top 0.1%
19.6%
2
Epigenetics & Chromatin
42 papers in training set
Top 0.1%
14.5%
3
Clinical Epigenetics
53 papers in training set
Top 0.1%
12.5%
4
BMC Genomics
328 papers in training set
Top 0.8%
3.6%
50% of probability mass above
5
Stem Cell Reports
118 papers in training set
Top 0.2%
3.6%
6
Scientific Reports
3102 papers in training set
Top 41%
3.1%
7
Computational and Structural Biotechnology Journal
216 papers in training set
Top 3%
2.1%
8
Genes
126 papers in training set
Top 0.6%
2.1%
9
BMC Biology
248 papers in training set
Top 0.8%
1.9%
10
The FASEB Journal
175 papers in training set
Top 0.9%
1.8%
11
PLOS ONE
4510 papers in training set
Top 53%
1.7%
12
EMBO Reports
88 papers in training set
Top 0.1%
1.7%
13
Cell Reports
1338 papers in training set
Top 26%
1.5%
14
Nature Communications
4913 papers in training set
Top 53%
1.5%
15
Human Molecular Genetics
130 papers in training set
Top 2%
1.3%
16
Biology Open
130 papers in training set
Top 1%
1.3%
17
Genome Biology
555 papers in training set
Top 5%
1.2%
18
Nucleic Acids Research
1128 papers in training set
Top 13%
1.2%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
1.0%
20
Bioinformatics
1061 papers in training set
Top 9%
0.8%
21
Stem Cells
28 papers in training set
Top 0.5%
0.8%
22
Life Science Alliance
263 papers in training set
Top 2%
0.8%
23
Molecular and Cellular Biology
40 papers in training set
Top 0.4%
0.8%
24
Cell Death Discovery
51 papers in training set
Top 1%
0.8%
25
Oncotarget
15 papers in training set
Top 0.4%
0.8%
26
Communications Biology
886 papers in training set
Top 23%
0.8%
27
Molecular Omics
21 papers in training set
Top 0.4%
0.7%
28
Genome Research
409 papers in training set
Top 4%
0.7%
29
The EMBO Journal
267 papers in training set
Top 6%
0.6%
30
Development
440 papers in training set
Top 4%
0.6%